Medtronic PLC. currently carries an SIA SMAX Score of 2 out of 10, indicating limited alignment across SIA technical and relative strength indicators. The stock appears in the SIA S&P 100 Index Report, where it is currently positioned at 83 out of 100 and resides within the unfavoured zone of the report. Relative positioning has weakened in recent periods, with MDT moving down 21 positions over the past month and a further 8 positions over the past week.
From a technical perspective, initial support appears at $86.50, followed by longer term support aligned with the 2020 positive trend near $78.34 and additional support at $64.27. On the upside, initial 3-box reversal resistance is identified at $95.50, followed by resistance near $105.44 associated with 2021 levels, and further overhead resistance at $118.74 marking a previous high level. The most recent Point & Figure signal registered a double bottom, suggesting continued technical pressure.
Over the past month, MDT has declined 12.41%, with a 12.10% decline over the past quarter and a 2.65% decline over the past year. By comparison, the S&P 100 Index benchmark declined 2.47% over the past month and 4.71% over the past quarter, but advanced 21.40% over the past year.
Sector dynamics may continue to weigh on performance. Health Services currently ranks as an unfavoured sector within the SIA Sector Report, positioned 30 out of 31 sectors, which may contribute to relative weakness across constituents within the group.
Medtronic PLC is a multinational medical technology company that develops and manufactures devices and therapies used to treat a wide range of medical conditions. Headquartered in Dublin, the company focuses on cardiovascular devices, surgical technologies, neuroscience, and diabetes management, with innovations aimed at improving patient outcomes, reducing healthcare costs, and expanding access to advanced medical treatments globally.
Disclaimer: SIACharts Inc. specifically represents that it does not give investment advice or advocate the purchase or sale of any security or investment whatsoever. This information has been prepared without regard to any particular investors investment objectives, financial situation, and needs. None of the information contained in this document constitutes an offer to sell or the solicitation of an offer to buy any security or other investment or an offer to provide investment services of any kind. As such, advisors and their clients should not act on any recommendation (express or implied) or information in this report without obtaining specific advice in relation to their accounts and should not rely on information herein as the primary basis for their investment decisions. Information contained herein is based on data obtained from recognized statistical services, issuer reports or communications, or other sources, believed to be reliable. SIACharts Inc. nor its third party content providers make any representations or warranties or take any responsibility as to the accuracy or completeness of any recommendation or information contained herein and shall not be liable for any errors, inaccuracies or delays in content, or for any actions taken in reliance thereon. Any statements nonfactual in nature constitute only current opinions, which are subject to change without notice.
